← Back to Clinical Trials
Recruiting NCT07238699

An Evaluation of the Safety and Tolerability of Ocular Lubricants

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Dry Eye Disease
Sponsor Alcon Research
Study Type INTERVENTIONAL
Phase N/A
Enrollment 148
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-03-04
Completion 2026-08
Interventions
FID123440 test formulationFID123437 test formulationFID123440 test formulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to evaluate the safety and tolerability of two new artificial tear formulations in subjects with moderate dry eye disease.

Eligibility Criteria

Inclusion Criteria: * Subject must be willing and able to understand and sign an ethics committee approved informed consent form. * Subject must be willing and able to attend all study visits as required by the protocol. * Subject must exhibit symptoms of dry eye at the Screening Visit. * Subject must currently use artificial tears. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Has any known active ocular disease and/or infection. * Has any known infection or inflammation that requires treatment or has a systemic condition that, in the opinion of the investigator, may affect a study outcome variable. * Any ocular injury to either eye in the 12 weeks prior to screening. * Current wearer of contact lenses or has a history of contact lens wear within the previous 1 month. * Other protocol-defined exclusion criteria may apply.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}